Arrowstreet Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Arrowstreet Capital’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-54,548	Closed	-$169K	–	1662
2021 Q4	$169K	Buy	+54,548	New	+$184K	﹤0.01%	1385
2020 Q3	–	Sell	-197,524	Closed	-$861K	–	2664
2020 Q2	$861K	Buy	197,524 +151,024	+325%	+$679K	﹤0.01%	1827
2020 Q1	$176K	Sell	46,500 -8,900	-16%	-$43.7K	﹤0.01%	1748
2019 Q4	$350K	Buy	+55,400	New	+$326K	﹤0.01%	1550
2015 Q2	–	Sell	-36,860	Closed	-$387K	–	1393
2015 Q1	$387K	Buy	+36,860	New	+$504K	﹤0.01%	874

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Arrowstreet Capital's BDSI Position: Q1 2022 in Review

Arrowstreet Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 54,548 shares — an estimated $169K sold.

Arrowstreet Capital first reported a position in BDSI in Q1 2015 and held it in 5 quarters. The position peaked at $861K in Q2 2020. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Arrowstreet Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Arrowstreet Capital sold 54,548 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $169K.
Arrowstreet Capital first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 5 quarters.
Arrowstreet Capital's BioDelivery Sciences International, Inc. position peaked at $861K in Q2 2020.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Arrowstreet Capital's 13F filing for Q1 2022, filed 13 May 2022.